이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
STAAR Surgical 관리
관리 기준 확인 0/4
STAAR Surgical's CEO는 Tom Frinzi, Jan2023 에 임명되었습니다 의 임기는 1.58 년입니다. 총 연간 보상은 $ 10.22M, 7.7% 로 구성됩니다. 7.7% 급여 및 92.3% 보너스(회사 주식 및 옵션 포함). 는 $ 862.71K 가치에 해당하는 회사 주식의 0.046% 직접 소유합니다. 862.71K. 경영진과 이사회의 평균 재임 기간은 각각 1.6 년과 2.9 년입니다.
주요 정보
Tom Frinzi
최고 경영자
US$10.2m
총 보상
| CEO 급여 비율 | 7.7% |
| CEO 임기 | 1.7yrs |
| CEO 소유권 | 0.05% |
| 경영진 평균 재임 기간 | 1.7yrs |
| 이사회 평균 재임 기간 | 3yrs |
최근 관리 업데이트
Recent updates
STAAR Surgical: Expecting A Re-Acceleration In Growth As Investments Materialize
Sep 05Results: STAAR Surgical Company Exceeded Expectations And The Consensus Has Updated Its Estimates
Aug 10
STAAR Surgical Company's (NASDAQ:STAA) Popularity With Investors Is Clear
Aug 05The Returns At STAAR Surgical (NASDAQ:STAA) Aren't Growing
Jul 12Is There Now An Opportunity In STAAR Surgical Company (NASDAQ:STAA)?
May 27Market Participants Recognise STAAR Surgical Company's (NASDAQ:STAA) Revenues Pushing Shares 30% Higher
Apr 26STAAR Surgical Stock: I Don't See A Great Path Forward, Despite The Recent Surge
Apr 05STAAR Surgical (NASDAQ:STAA) Shareholders Will Want The ROCE Trajectory To Continue
Mar 25STAAR Surgical Company: Potential Buy After Long-Term Valuation Downgrade
Mar 13STAAR Surgical Company (NASDAQ:STAA) Looks Just Right With A 28% Price Jump
Mar 07Is There Now An Opportunity In STAAR Surgical Company (NASDAQ:STAA)?
Jan 31With STAAR Surgical Company (NASDAQ:STAA) It Looks Like You'll Get What You Pay For
Jan 05Returns On Capital Are Showing Encouraging Signs At STAAR Surgical (NASDAQ:STAA)
Nov 30Is There An Opportunity With STAAR Surgical Company's (NASDAQ:STAA) 21% Undervaluation?
Nov 12Is STAAR Surgical Company (NASDAQ:STAA) Potentially Undervalued?
Oct 25Returns On Capital At STAAR Surgical (NASDAQ:STAA) Have Hit The Brakes
Aug 24Are STAAR Surgical Company (NASDAQ:STAA) Investors Paying Above The Intrinsic Value?
Jul 02Is Now The Time To Look At Buying STAAR Surgical Company (NASDAQ:STAA)?
Jun 17Here's Why We Think STAAR Surgical (NASDAQ:STAA) Might Deserve Your Attention Today
May 13A Look At The Fair Value Of STAAR Surgical Company (NASDAQ:STAA)
Mar 26STAAR Surgical (NASDAQ:STAA) Is Looking To Continue Growing Its Returns On Capital
Mar 12Should You Investigate STAAR Surgical Company (NASDAQ:STAA) At US$68.56?
Feb 13Here's Why We Think STAAR Surgical (NASDAQ:STAA) Might Deserve Your Attention Today
Jan 28Calculating The Fair Value Of STAAR Surgical Company (NASDAQ:STAA)
Dec 15The Return Trends At STAAR Surgical (NASDAQ:STAA) Look Promising
Dec 01What Is STAAR Surgical Company's (NASDAQ:STAA) Share Price Doing?
Oct 26Keep Adding To STAAR Surgical Longs, Buy Thesis Remains
Sep 20Should You Be Adding STAAR Surgical (NASDAQ:STAA) To Your Watchlist Today?
Sep 05STAAR Surgical Company (NASDAQ:STAA) Shares Could Be 24% Above Their Intrinsic Value Estimate
Aug 21STAAR Surgical rises 15% on Q2 result beat
Aug 11CEO 보상 분석
| 날짜 | 총 보상 | 급여 | 회사 수익 |
|---|---|---|---|
| Jun 28 2024 | n/a | n/a | US$17m |
| Mar 29 2024 | n/a | n/a | US$15m |
| Dec 29 2023 | US$10m | US$788k | US$21m |
| Sep 29 2023 | n/a | n/a | US$19m |
| Jun 30 2023 | n/a | n/a | US$26m |
| Mar 31 2023 | n/a | n/a | US$33m |
| Dec 30 2022 | US$274k | n/a | US$40m |
| Sep 30 2022 | n/a | n/a | US$38m |
| Jul 01 2022 | n/a | n/a | US$34m |
| Apr 01 2022 | n/a | n/a | US$29m |
| Dec 31 2021 | US$250k | n/a | US$28m |
| Oct 01 2021 | n/a | n/a | US$23m |
| Jul 02 2021 | n/a | n/a | US$21m |
| Apr 02 2021 | n/a | n/a | US$11m |
| Jan 01 2021 | US$182k | n/a | US$6m |
보상 대 시장: Tom 의 총 보상 ($USD 10.22M )은 US 시장( $USD 5.62M ).
보상과 수익: Tom 의 보상은 작년에 20% 이상 증가한 반면 회사 수익은 20% 이상 감소했습니다.
CEO
Tom Frinzi (68 yo)
1.7yrs
테뉴어
US$10,220,581
보상
Mr. Thomas G. Frinzi, also known as Tom, serves as Executive Chairman of the Board at ViaLase, Inc. since November 2022 and joined the company in November 2022. He serves as Executive Chair at Aurion Biote...
리더십 팀
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| President | 1.7yrs | US$10.22m | 0.046% $ 847.2k | |
| Chief Financial Officer | 4.2yrs | US$2.82m | 0.070% $ 1.3m | |
| Chief Operating Officer | 1.4yrs | US$3.42m | 0.0089% $ 162.2k | |
| Chief Technology Officer | 7.5yrs | US$2.41m | 0.036% $ 661.8k | |
| Chief Medical Officer | 6.9yrs | US$2.48m | 0.064% $ 1.2m | |
| Vice President of Investor Relations & Corporate Development | no data | 데이터 없음 | 데이터 없음 | |
| General Counsel & Corporate Secretary | less than a year | 데이터 없음 | 데이터 없음 | |
| Chief Marketing Officer | less than a year | 데이터 없음 | 데이터 없음 | |
| Senior Vice President of Commercial Operations - North America & APAC | 7.8yrs | US$2.54m | 0.060% $ 1.1m | |
| Chief Clinical | 1.4yrs | 데이터 없음 | 0.0061% $ 112.2k | |
| Senior Vice President of Operations | no data | 데이터 없음 | 0.066% $ 1.2m |
1.7yrs
평균 재임 기간
60.5yo
평균 연령
경험이 풍부한 관리: STAA 의 관리팀은 경험 (평균 재직 기간 1.6 년)으로 간주되지 않으므로 새로운 팀을 추천합니다.
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| President | 4.3yrs | US$10.22m | 0.046% $ 847.2k | |
| Lead Independent Director | 8.7yrs | US$294.87k | 0.031% $ 564.2k | |
| Independent Director | 2.3yrs | US$259.96k | 0.031% $ 571.5k | |
| Independent Director | less than a year | US$99.69k | 0.0093% $ 170.3k | |
| Member of Optometric Advisory Council | 15.8yrs | 데이터 없음 | 데이터 없음 | |
| Independent Director | less than a year | 데이터 없음 | 0.0086% $ 156.7k | |
| Independent Director | less than a year | 데이터 없음 | 0.0072% $ 132.0k | |
| Independent Director | 3.7yrs | US$249.99k | 0.010% $ 189.8k |
3.0yrs
평균 재임 기간
55yo
평균 연령
경험이 풍부한 이사회: STAA 의 이사회는 경험(평균 재직 기간 2.9 년)으로 간주되지 않으므로 새 이사회가 필요합니다.